Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Center for Comprehensive Cancer Care, originally established as the oncology division of Delta Medix in Scranton, Pennsylvania, is a leading regional provider of multidisciplinary oncology services. The center offers a full spectrum of care including medical oncology, hematology, radiation oncology, and surgical interventions, supported by advanced diagnostic imaging and laboratory services. In 2021, the center was acquired by Lehigh Valley Health Network (LVHN) and integrated into the Lehigh Valley Topper Cancer Institute, expanding its access to specialized clinical trials and genomic testing. It serves as a critical clinical research site in Northeastern Pennsylvania, participating in numerous national oncology trials across various solid and hematologic malignancies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Center for Comprehensive Cancer Care.